By Josh White
Date: Tuesday 08 Jul 2025
(Sharecast News) - Niox Group reported strong first-half trading on Tuesday, driven by robust growth in both clinical and research revenues, and said it remained confident in its strategic plans despite some uncertainty around research demand.
| Niox Group reports strong start to 2025 | 14-May-2025 | ShareCast |
| Niox ends sale process as Keensight steps back | 11-Apr-2025 | ShareCast |
| Niox reports solid set of full-year results | 01-Apr-2025 | ShareCast |
| Niox confirms approach from Keensight, enters fo... | 20-Mar-2025 | ShareCast |
| Niox flags strong year, announces board changes | 16-Jan-2025 | ShareCast |
| Total Voting Rights | 31-Oct-2025 | 14:24 | RNS |
| Holding(s) in Company | 08-Oct-2025 | 13:08 | RNS |
| Holding(s) in Company | 02-Oct-2025 | 14:11 | RNS |
| Block listing Interim Review | 01-Oct-2025 | 15:55 | RNS |
| Total Voting Rights | 01-Oct-2025 | 15:00 | RNS |
| Circassia raises £200m in landmark biotech IPO | 14-Mar-2014 | The Independent |
| Cat allergy group raises £200m in float | 14-Mar-2014 | Telegraph |
No recent information was found.
No recent information was found.
| Currency | UK Pounds |
| Share Price | 67.00p |
| Change Today | -1.00p |
| % Change | -1.47 % |
| 52 Week High | 76.00p |
| 52 Week Low | 54.60p |
| Volume | 743,683 |
| Shares Issued | 417.88m |
| Market Cap | £279.98m |
| Beta | 0.79 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 3 |
| Buy | 2 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 5 |

| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 15-May-25 | 23-May-24 |
| Paid | 16-Jun-25 | 24-Jun-24 |
| Amount | 1.25p | 1.00p |
| Time | Volume / Share Price |
| 16:35 | 15,864 @ 67.00p |
| 16:35 | 578 @ 67.00p |
| 16:35 | 490 @ 67.00p |
| 16:35 | 1,466 @ 67.00p |
| 16:35 | 605 @ 67.00p |
You are here: research